The World Health Organization warned today that the spread of resistance to antibiotics and other medicines could turn routine surgeries and childbirth into life-threatening situations and jeopardize the future of modern medicine.
“Antibiotic resistance, more widely known as antimicrobial resistance, or AMR, is widespread and poses a threat to the future of modern medicine,” said Jean-Pierre Niemazi, a WHO expert.
Të lidhura
None found
Cancer patients and people with chronic illnesses are also at greater risk from infections caused by bacteria, viruses or fungi that no longer respond to available treatments.
Over time, bacteria have developed the ability to withstand the medicines designed to fight them, rendering many treatments ineffective.
As part of its awareness week, which runs from November 18 to 24, the WHO is urging countries to step up measures against antimicrobial resistance.
Antimicrobial resistance could cause 39 million deaths worldwide over the next 25 years.
More than 1 million people died in 2021 as a direct result of this resistance, according to estimates, Niemazi said.
“Drug-resistant infections have been taking lives for years without us realizing it,” he said. According to the WHO, bacteria that do not respond to antibiotics directly cause more than one million deaths and contribute to nearly five million deaths each year.
If current trends continue, antimicrobial resistance could cause 39 million deaths worldwide over the next 25 years, Niemazi added.
While the number of bacteria resistant to widely used medicines is growing, the development of new antibiotics is progressing very slowly.
“Preventing infections is one of the most effective ways to reduce the need for antibiotics,” said Pravarsha Prakash, a WHO expert.
However, WHO guidelines for infection prevention at the national level have been fully implemented by only slightly more than one-third of countries.
The WHO said many countries are still far from meeting the targets adopted by the World Health Assembly in 2024, which are to be achieved by 2030.
The targets include infection prevention, the use of medicines in hospitals, diagnostic capacity and monitoring antimicrobial resistance.








